Ferrous succinate clinical trials
Ferrous succinate is named as an intervention in 2 current clinical trials in our China register. 1 is recruiting patients now. The most common phase is Phase 2. The sponsor with the most trials is Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1). The most-studied condition is Gastric Neoplasms.
What health systems spend on Ferrous succinate
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
How Ferrous succinate works
All drug targets →- FatiguePhase 3
- Gastrointestinal hemorrhagePhase 3
- AnemiaPhase 3
- Burning mouth syndromePhase 3
- CancerPhase 3
- Chronic kidney diseasePhase 3
- FibromyalgiaPhase 3
- Hip fracturePhase 3
- Heart failurePhase 2/3
- Autism spectrum disorderPhase 2
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL1200830, CC BY-SA 3.0. The Guide to Pharmacology has no record of this medicine, so its targets rest on ChEMBL alone. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Ferrous succinate
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- IEIreland: 2 products on the HPRA listEach product record links to the HPRA, which publishes the leaflet and SmPC.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Ferrous succinate
- ChEMBL
- CHEMBL1200830
- DrugBank
- DB13257
- PubChem CID
- 24393
- CAS number
- 7720-78-7
- FDA UNII
- 2IDP3X9OUD
- Wikidata
- Q214863
- Wikipedia
- Iron(II) sulfate
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Ferrous succinate
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery
NCT05714007 · ClinicalTrials.gov ↗ · Perioperative Anemia, Surgery, Spinal Deformity
|
Phase 4 | Recruiting | Peking Union Medical College Hospital | China |
|
Exploring the Efficacy of Ferrous Sulfate/Ferrous Succinate Combined With Serplulimab and SOX Regimen in Neoadjuvant Therapy for Gastric Cancer: A Prospective Cohort Study
NCT07872696 · ClinicalTrials.gov ↗ · Gastric Neoplasms
|
Phase 2 | Not yet open | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Ferrous succinate
5 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
| Peking Union Medical College Hospital | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Ferrous succinate trials
How many clinical trials are testing Ferrous succinate?
2 current trials in our China register name Ferrous succinate as a drug or biological intervention, as of the registry sync on 15 October 2026. Completed and withdrawn studies are not counted.
Are Ferrous succinate trials recruiting patients?
Yes. 1 of the 2 trials is recruiting: 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Ferrous succinate clinical trials?
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) and Peking Union Medical College Hospital (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Ferrous succinate works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Ferrous succinate works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Ferrous succinate (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 15 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.